-
The high-end 'medical grade' female hygiene products into the market focus
The sales of "medical grade" sanitary napkins are increasing year by year, and the products are constantly updated and iterated, which not only meet t...
2022-10-21 15:00 -
China's original 'non-invasive' surgical equipment is exported to Colombia for clinical treatment an...
A set of "Haifudao" focused ultrasound tumor treatment system, an original "non-invasive" surgical equipment in China, was sent from Chongqing to Colo...
2022-10-21 15:00 -
The 2022 edition of the list of the world's top 2 percent scientists has been announced: Dr. Liu Y...
Ranked the second in the field of life sciences in China!
2022-10-20 09:04 -
Not as good as a placebo? Relmada Therapeutics Shares plunge 80% after Phase 3 trial of New Drug for...
The number of people suffering from depression jumped by 53 million in the wake of COVID-19.
2022-10-20 09:03 -
When is 'water inverse' going on? Biogen's ALS drug approval delayed to next April
Bojian appears to be experiencing "water retrograde".
2022-10-20 09:03 -
Danning tablets have been successfully exported to Canada and entered the international mainstream d...
Chinese medicine gall tablets have been officially delivered to Toronto, Canada. This means that Tylenol tablets have officially entered the internati...
2022-10-20 09:03 -
Sodium thiosulfate has been approved by the FDA to reduce hearing loss in children caused by chemoth...
The FDA finally approved Fennec Pharmaceuticals' Pedmark (sodium thiosulfate) on the market on September 20 to reduce hearing loss caused by cisplatin...
2022-10-19 11:37 -
Lilly wins FDA expedited approval for Retevmo
Eli Lilly and Company announced that the U.S. FDA has accelerated the approval of Retevmo (selpercatinib) for the expanded indication of patients with...
2022-10-19 11:37 -
Legendary Bio BCMA CAR-T approved for sale in Japan
Legendary Creatures (NASDAQ: LEGN announced that the Ministry of Health, labor and Welfare of Japan has approved CARVYKTI® (Ciltacabtagene Autoleucel...
2022-10-19 11:37 -
Flu new drug approved only 1 year, Shi Yao Ou Yi that is the first copy! Roche responds...
Shiyao Ouyi's Mabaloxavir tablets were approved for marketing, giving China its first copycat of the single-dose oral anti-influenza drug.
2022-10-19 11:37
Hot News
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- Guangdong Jieyang Puts into Op... Jul 16, 2025
- BASF Launches Second Round of ... Jul 24, 2025
Related Products
Related Producers
